CC
ZYME icon

Clearline Capital’s Zymeworks ZYME Stock Holding History

Clearline Capital’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-153,136
Closed -$971K – 131
2023
Q3 		$971K Buy
+153,136
New +$1.13M 0.08% 101
2022
Q4 		– Sell
-193,288
Closed -$1.19M – 149
2022
Q3 		$1.19M Hold
193,288
– – 0.14% 94
2022
Q2 		$1.02M Buy
+193,288
New +$1.17M 0.13% 88

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Clearline Capital's ZYME Position: Q4 2023 in Review

Clearline Capital sold out of Zymeworks (ZYME) in Q4 2023, closing a stake of 153,136 shares — an estimated $971K sold.

Clearline Capital first reported a position in ZYME in Q2 2022 and held it in 3 quarters. The position peaked at $1.19M in Q3 2022. 157 funds tracked by Wall St. Rank hold ZYME as of Q4 2023.

  • Clearline Capital reported no remaining Zymeworks position as of Q4 2023 after selling out during the quarter.
  • Clearline Capital sold 153,136 Zymeworks shares in Q4 2023, an estimated $971K.
  • Clearline Capital first reported a position in Zymeworks in Q2 2022 and held it in 3 quarters.
  • Clearline Capital's Zymeworks position peaked at $1.19M in Q3 2022.
  • 157 funds tracked by Wall St. Rank held Zymeworks as of Q4 2023.

Based on Clearline Capital's 13F filing for Q4 2023, filed 14 Feb 2024.